Human Genome Epidemiology Literature Finder
Records 1 - 4 (of 4 Records) |
Query Trace: Fatigue and KIT[original query] |
---|
The outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure - one institution study. BMC cancer 2012 12 (1): 107. Rutkowski Piotr, Bylina El?bieta, Klimczak Anna, Switaj Tomasz, Falkowski S?awomir, Kroc Jacek, Lugowska Iwona, Brzeskwiniewicz Magdalena, Melerowicz Wojciech, Osuch Czes?aw, Mierzejewska Ewa, Wasielewski Kacper, Wo?niak Agnieszka, Grzesiakowska Urszula, Nowecki Zbigniew I, Siedlecki Janusz A, Limon Janu |
Cabozantinib for the treatment of progressive metastatic medullary thyroid cancer. Expert review of clinical pharmacology 2015 Nov 1-11. Krajewska Jolanta, Olczyk Tomasz, Jarzab Barba |
A Randomized Phase II Study of Nivolumab Monotherapy or Nivolumab Combined with Ipilimumab in Patients with Advanced Gastrointestinal Stromal Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 2021 8 28 (1): 84-94. Singh Arun S, Hecht J Randolph, Rosen Lee, Wainberg Zev A, Wang Xiaoyan, Douek Michael, Hagopian Anahis, Andes Rachel, Sauer Lauren, Brackert Sandra R, Chow Warren, DeMatteo Ronald, Eilber Fritz Christian, Glaspy John A, Chmielowski Barto |
Efficacy and safety of ripretinib in patients with KIT-altered metastatic melanoma. ESMO open 2022 6 7 (4): 100520. Janku F, Bauer S, Shoumariyeh K, Jones R L, Spreafico A, Jennings J, Psoinos C, Meade J, Ruiz-Soto R, Chi |
- Page last reviewed:Feb 1, 2024
- Page last updated:Mar 25, 2024
- Content source: